Cyclo Therapeutics, Inc.

CYTHNASDAQHealthcare

$0.72

+$0.00(+0.00%)

Market Cap$23589778

P/E Ratio—

52W High$1.6199

52W Low$0.55

Avg Volume1.9M

Open$0.72

Beta-0.57

Overview

Cyclo Therapeutics, Inc. (CYTH) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CYTH · as of Mar 18, 2024

Latest filing snapshot

-1-11.11%vs prior year

Cyclo Therapeutics, Inc. (CYTH) employee data is sourced from the annual SEC 10-K filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2023-12-31·Full-time · Global

Total Employees

Change (1Y)

-1

Growth % (1Y)

-11.11%

Revenue / Employee

$134.6K

Net Income / Employee

$-2.51M

Market Cap

$24M

CYTH Employee Count

2008 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-03-18	2023-12-31	8	-1	-11.11%
2023-03-17	2022-12-31	9	+0	+0.00%
2022-03-11	2021-12-31	9	+1	+12.50%
2021-03-12	2020-12-31	8	+0	+0.00%
2020-03-30	2019-12-31	8	+3	+60.00%
2019-03-15	2018-12-31	5	+1	+25.00%
2018-04-16	2017-12-31	4	-2	-33.33%
2017-03-17	2016-12-31	6	-3	-33.33%
2016-03-30	2015-12-31	9	+0	+0.00%
2015-03-27	2014-12-31	9	+4	+80.00%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Drug Manufacturers - Specialty & Generic

#SymbolCompanyEmployeesMkt Cap

LakeShore Biopharma Co., Ltd

Elevation Oncology, Inc.

Cyclo Therapeutics, Inc.YOU

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CYTH peer comparison

About CYTH employees

CYTH Employees · Headcount

Cyclo Therapeutics, Inc. (CYTH) employee data is sourced from the annual SEC 10-K filing. As of 2023, Cyclo Therapeutics, Inc. had 8 full-time employees globally. Full-time employees only. Global consolidated headcount.

Cyclo Therapeutics, Inc. employs 8 full-time employees as of the latest filing within the Drug Manufacturers - Specialty & Generic industry. Revenue per employee stands at $134,551, reflecting the company's operational efficiency.

Cyclo Therapeutics, Inc.'s workforce decreased by 1 (11.11%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Cyclo Therapeutics, Inc.'s revenue per employee of $134,551 positions it among the notable performers in the Drug Manufacturers - Specialty & Generic sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CYTH Employees · 5 questions

As of the latest SEC 10-K filing (2023), Cyclo Therapeutics, Inc. had 8 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Cyclo Therapeutics, Inc. employee counthow many employees does Cyclo Therapeutics, Inc. haveCYTH total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-03-18